tiprankstipranks
Trending News
More News >
Neurocrine Biosciences (NBIX)
:NBIX
US Market

Neurocrine (NBIX) Ratios

Compare
1,395 Followers

Neurocrine Ratios

NBIX's free cash flow for Q1 2025 was $0.98. For the 2025 fiscal year, NBIX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.70 2.45 2.70 3.96 5.45
Quick Ratio
2.64 2.40 2.64 3.83 5.30
Cash Ratio
0.49 0.38 0.49 1.39 4.29
Solvency Ratio
0.26 0.27 0.26 0.14 0.68
Operating Cash Flow Ratio
0.63 0.60 0.63 1.04 1.23
Short-Term Operating Cash Flow Coverage
2.00 2.29 2.00 0.00 0.00
Net Current Asset Value
$ 792.60M$ 587.60M$ 792.60M$ 274.30M$ 407.70M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.13 0.11 0.21 0.24
Debt-to-Equity Ratio
0.15 0.19 0.15 0.32 0.37
Debt-to-Capital Ratio
0.13 0.16 0.13 0.24 0.27
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.20 0.22
Financial Leverage Ratio
1.39 1.46 1.39 1.51 1.54
Debt Service Coverage Ratio
1.16 1.58 1.16 8.02 19.41
Interest Coverage Ratio
35.07 54.54 35.07 7.63 9.72
Debt to Market Cap
0.01 0.01 0.01 0.04 0.04
Interest Debt Per Share
2.82 4.43 2.82 4.93 4.78
Net Debt to EBITDA
0.00 0.50 0.00 0.46 -1.16
Profitability Margins
Gross Profit Margin
98.44%97.90%98.44%98.74%99.03%
EBIT Margin
16.73%17.84%16.73%18.33%31.31%
EBITDA Margin
17.77%18.97%17.77%19.29%32.14%
Operating Profit Margin
16.73%13.30%16.73%17.37%30.49%
Pretax Profit Margin
14.37%17.60%14.37%8.95%10.20%
Net Profit Margin
10.38%13.23%10.38%7.90%38.94%
Continuous Operations Profit Margin
10.38%13.23%10.38%7.90%38.94%
Net Income Per EBT
72.23%75.19%72.23%88.36%381.72%
EBT Per EBIT
85.90%132.36%85.90%51.50%33.46%
Return on Assets (ROA)
6.52%7.68%6.52%4.32%23.48%
Return on Equity (ROE)
9.05%11.19%9.05%6.52%36.17%
Return on Capital Employed (ROCE)
13.60%9.66%13.60%10.78%20.60%
Return on Invested Capital (ROIC)
8.99%6.82%8.99%9.52%78.63%
Return on Tangible Assets
6.63%7.76%6.63%4.32%23.48%
Earnings Yield
1.35%1.94%1.35%1.11%4.56%
Efficiency Ratios
Receivables Turnover
4.25 4.30 4.25 6.11 6.66
Payables Turnover
0.34 0.36 0.34 0.28 0.26
Inventory Turnover
0.66 1.04 0.66 0.47 0.36
Fixed Asset Turnover
10.22 5.43 10.22 7.28 8.21
Asset Turnover
0.63 0.58 0.63 0.55 0.60
Working Capital Turnover Ratio
1.81 2.02 1.81 1.46 1.91
Cash Conversion Cycle
-420.78 -564.12 -420.78 -476.28 -357.16
Days of Sales Outstanding
85.81 84.97 85.81 59.73 54.83
Days of Inventory Outstanding
552.22 352.13 552.22 778.50 1.01K
Days of Payables Outstanding
1.06K 1.00K 1.06K 1.31K 1.42K
Operating Cycle
638.03 437.10 638.03 838.23 1.07K
Cash Flow Ratios
Operating Cash Flow Per Share
3.54 3.99 3.54 2.71 2.45
Free Cash Flow Per Share
3.37 3.70 3.37 2.46 2.34
CapEx Per Share
0.17 0.29 0.17 0.25 0.12
Free Cash Flow to Operating Cash Flow
0.95 0.93 0.95 0.91 0.95
Dividend Paid and CapEx Coverage Ratio
20.57 13.78 20.57 10.96 20.96
Capital Expenditure Coverage Ratio
20.57 13.78 20.57 10.96 20.96
Operating Cash Flow Coverage Ratio
1.29 0.91 1.29 0.58 0.55
Operating Cash Flow to Sales Ratio
0.23 0.21 0.23 0.23 0.22
Free Cash Flow Yield
2.82%2.81%2.82%2.89%2.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
74.06 51.55 74.06 89.92 21.91
Price-to-Sales (P/S) Ratio
7.69 6.82 7.69 7.11 8.53
Price-to-Book (P/B) Ratio
6.70 5.77 6.70 5.86 7.92
Price-to-Free Cash Flow (P/FCF) Ratio
35.44 35.60 35.44 34.56 41.01
Price-to-Operating Cash Flow Ratio
33.71 33.02 33.71 31.41 39.05
Price-to-Earnings Growth (PEG) Ratio
1.07 0.87 1.07 -1.15 0.02
Price-to-Fair Value
6.70 5.77 6.70 5.86 7.92
Enterprise Value Multiple
43.24 36.45 43.24 37.30 25.39
Enterprise Value
11.44B 13.05B 11.44B 8.16B 8.53B
EV to EBITDA
43.24 36.45 43.24 37.30 25.39
EV to Sales
7.69 6.92 7.69 7.20 8.16
EV to Free Cash Flow
35.44 36.09 35.44 34.99 39.22
EV to Operating Cash Flow
33.71 33.47 33.71 31.80 37.35
Tangible Book Value Per Share
17.38 22.48 17.38 14.52 12.10
Shareholders’ Equity Per Share
17.83 22.85 17.83 14.52 12.10
Tax and Other Ratios
Effective Tax Rate
0.28 0.25 0.28 0.12 -2.82
Revenue Per Share
15.54 19.32 15.54 11.98 11.23
Net Income Per Share
1.61 2.56 1.61 0.95 4.37
Tax Burden
0.72 0.75 0.72 0.88 3.82
Interest Burden
0.86 0.99 0.86 0.49 0.33
Research & Development to Revenue
0.31 0.30 0.31 0.29 0.26
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.12 0.10 0.12 0.12 0.10
Income Quality
2.20 1.56 2.20 2.86 0.56
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis